Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:00 pm Purchase | 2026-06-30 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Tibbs Isaiah | 2,089,000 4.630% | 258,993 (+14.15%) | Filing History |
| 2026-03-12 3:38 pm Purchase | 2026-02-19 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Tibbs Isaiah | 1,830,007 8.670% | 1,830,007 (New Position) | Filing History |
| 2025-08-14 9:02 pm Purchase | 2025-06-30 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Armistice Capital, LLC | 63,308 4.990% | 34,081 (+116.61%) | Filing History |
| 2025-05-15 3:12 pm Purchase | 2025-03-31 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Armistice Capital, LLC | 29,227 9.990% | 29,227 (New Position) | Filing History |
| 2025-04-04 7:17 pm Purchase | 2025-03-31 | 13D | CERO THERAPEUTICS HLDGS INC CERO | ATWOOD BRIAN G | 25,590 9.900% | 15,470 (+152.87%) | Filing History |
| 2025-02-07 5:21 pm Purchase | 2025-02-07 | 13D | CERO THERAPEUTICS HLDGS INC CERO | ATWOOD BRIAN G | 10,120 6.700% | 254 (+2.57%) | Filing History |
| 2024-12-17 7:26 pm Sale | 2024-12-13 | 13G | CERO THERAPEUTICS HLDGS INC CERO | YK Bioventures Opportunities GP I, LLC | 9 0.000% | -11,301 (-99.92%) | Filing History |
| 2024-12-13 7:18 pm Purchase | 2024-12-10 | 13G | MERIDA MERGER CORP I COM MCMJ | Corey Lawrence | 8,529,316 5.700% | 8,529,316 (New Position) | Filing History |
| 2024-11-20 4:06 pm Purchase | 2024-09-24 | 13G | CERO THERAPEUTICS HLDGS INC CERO | SLOAN STUART M | 10,534 14.000% | 10,036 (+2015.26%) | Filing History |
| 2024-11-20 4:01 pm Purchase | 2024-02-14 | 13G | CERO THERAPEUTICS HLDGS INC CERO | SLOAN STUART M | 498 6.700% | 498 (New Position) | Filing History |
| 2024-11-14 8:18 pm Purchase | 2024-08-02 | 13G | CERO THERAPEUTICS HLDGS INC CERO | YK Bioventures Opportunities GP I, LLC | 11,310 15.000% | 11,310 (New Position) | Filing History |
| 2024-10-30 8:58 pm Purchase | 2024-09-25 | 13D | CERO THERAPEUTICS HLDGS INC CERO | ATWOOD BRIAN G | 9,866 13.400% | 9,866 (New Position) | Filing History |
| 2024-02-22 09:06 am Sale | 2023-12-31 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Shaolin Capital Management LLC | 0 0.000% | -374 (Position Closed) | Filing History |
| 2024-02-20 5:18 pm Sale | 2024-02-14 | 13D | CERO THERAPEUTICS HLDGS INC CERO | PHOENIX BIOTECH SPONSOR LLC | 508 6.800% | -2,140 (-80.82%) | Filing History |
| 2024-02-08 12:31 pm Sale | 2023-12-31 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Saba Capital Management, L.P. | 0 0.000% | -606 (Position Closed) | Filing History |
| 2023-02-14 3:45 pm Sale | 2022-12-30 | 13G | CERO THERAPEUTICS HLDGS INC CERO | THE GOLDMAN SACHS GROUP, INC. GS | 0 0.000% | -125 (Position Closed) | Filing History |
| 2023-02-14 1:51 pm Sale | 2022-12-31 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Beryl Capital Management LLC | 0 0.000% | -615 (Position Closed) | Filing History |
| 2023-02-14 06:39 am Purchase | 2022-12-31 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Saba Capital Management, L.P. | 606 6.600% | 127 (+26.51%) | Filing History |
| 2023-02-13 8:05 pm Purchase | 2022-12-31 | 13G | CERO THERAPEUTICS HLDGS INC CERO | Shaolin Capital Management LLC | 374 6.580% | 374 (New Position) | Filing History |
| 2023-02-13 5:21 pm Sale | 2022-12-30 | 13G | BIOTECH ACQUISITION CO USD CL BIOT | THE GOLDMAN SACHS GROUP, INC. GS | 250,525 1.100% | -944,153 (-79.03%) | Filing History |